Mindpeak at AACR 2026 - Together with Revolune

April 16, 2026

We are pleased to announce that Mindpeak will be exhibiting at AACR 2026 in collaboration with Revolune.

At this year’s meeting, we will present a joint approach to simplifying spatial biology workflows by combining Revolune’s multiplex immunofluorescence (mIF) reagents with Mindpeak’s AI-powered image analysis - PhenoScout.

By integrating staining and analysis into a streamlined workflow, researchers can generate high-quality multiplex tissue data and efficiently derive meaningful biological insights. This supports key applications such as biomarker discovery and translational cancer research.

We believe that reducing complexity is essential to accelerating the adoption of spatial biology technologies. Together with Revolune, our goal is to make advanced multiplex workflows more accessible, scalable, and practical for real-world use.

For more details, please read the full press release:
https://lnkd.in/dSRZaEAw

If you are attending AACR 2026, we invite you to visit us at booth #1660

Press Release

Related reading

Press Release

8 min read

ZEISS and Mindpeak partner to advance Multiplex Immunofluorescence (mIF) solutions for pathology

The future of pathology is here!

‍ZEISS Microscopy and Mindpeak GmbH partner to develop an integrated Multiplex Immunofluorescence (mIF) solution, combining ZEISS’s advanced instruments with Mindpeak’s AI-powered pathology analysis.

Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF. The joint solution will integrate both companies' existing offerings to enhance the value for the users and address multiple market segments.The partnership combines complementary competencies and expands both companies’ reach in the growing mIF market.

…making excellence a habit! Mindpeak achieves ISO13485:2016 certification for its QMS

Today, we’re excited to share a major milestone: Mindpeak GmbH has officially achieved ISO 13485:2016 certification from the British Standards Institution (BSI)!

This globally recognized certification confirms that our Quality Management System meets the highest international standards for safety, reliability, and compliance in the medical device industry. It reflects our dedication to delivering innovative solutions that healthcare providers can trust.

At Mindpeak, quality is at the heart of everything we do. From product design to delivery, this certification underscores our commitment to ensuring that our products meet the most rigorous regulatory requirements while improving outcomes for patients and healthcare professionals alike.

This accomplishment wouldn’t have been possible without the dedication and expertise of our team. Here’s to continuing to raise the bar in quality, safety, and innovation!

Mindpeak and Sagis Diagnostics to launch Collaborative Study on AI-Enhanced Detection of Nail Mycosis

Mindpeak announces its collaboration with Sagis Dx to conduct a spearheading study, assessing the efficacy of the new Mindpeak Onychomycosis AI algorithm.

The Mindpeak Onychomycosis AI algorithm is designed to automate the process of detecting hyphae from multiple slides, by efficiently identifying target structures that may appear sparsely in whole-slide images. The algorithm aims to reduce the risk of missed diagnoses.

Read full article:https://lnkd.in/eHrpcezW

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting

Request consult